Top Markets
Coin of the day
Harrow Health, Inc. 8.625% Senior Notes due 2026 Harrow Health, Inc. 8.625% Senior Notes due 2026

Harrow Health, Inc. 8.625% Senior Notes due 2026

HROWL
Rang in Aktien #8091
Harrow, Inc. is a pharmaceutical company that specializes in the development,... Harrow, Inc. is a pharmaceutical company that specializes in the development, production, and distribution of innovative medications. Its business activities are primarily divided into two segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding division notably encompasses the operations of the ImprimisRx business. Co-founded by Mark L. Baum and Robert J. Kammer in January 2006, the firm maintains its corporate headquarters in Nashville, Tennessee.
Aktienkurs
$25.61
Zuletzt synchronisiert: 2025-10-10
Marktkapitalisierung
$1.37B
Veränderung (1 Tag)
0.20%
Veränderung (1 Jahr)
1.59%
Land
US
Handel Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)

Kategorie

EPS für Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)
EPS zum 2026 TTM: 0
Laut den aktuellen Finanzberichten und dem Aktienkurs von Harrow Health, Inc. 8.625% Senior Notes due 2026 beträgt das aktuelle EPS des Unternehmens (TTM) 0. Am Ende des Jahres 2026 betrug das EPS 0 gleich wie dem EPS von 2026, das 0 betrug.
EPS-Verlauf von Harrow Health, Inc. 8.625% Senior Notes due 2026 von 2026 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
Nicht genügend Daten für die angegebenen Daten.
EPS für ähnliche Unternehmen oder Wettbewerber